Importance of sympathetic activation for the expression of Na+-Ca2+ exchanger in end-stage failing human myocardium

European Heart Journal

Volumn 23, Issue 14, 2002, Pages 1118-1124

  Schillinger, W ^a   Schneider, H ^b   Minami, K ^c   Ferrari, R ^d   Hasenfuss, Gerd ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d UNIVERSITY OF FERRARA   (Italy)

Author keywords

Arrhythmia; Calcium; Catecholamines; Heart failure; Myocardium; Na+ Ca2+ exchanger

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM ION; CATECHOLAMINE; NEUROHORMONE; NORADRENALIN; SODIUM CALCIUM EXCHANGE PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HEART ARRHYTHMIA; HEART FAILURE; HEART TRANSPLANTATION; HEART VENTRICLE TACHYCARDIA; HEMODYNAMICS; HOLTER MONITORING; HUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; SODIUM CALCIUM EXCHANGE; SYMPATHETIC TONE;

EID: 0036629711     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2001.3044     Document Type: Article

References (28)

1. 2+-exchanger on the force-frequency relation. Basic Res Cardiol 1998; 93 (Suppl 1): 38-45.
2. 2+ exchanger in end-stage human heart failure. Circ Res 1994; 75: 443-53.
3. 2+ exchange activity in patients with end-stage heart failure. Cardiovasc Res 1996; 31: 48-54.
4. 2+ exchanger in failing human myocardium. Circulation 1996; 94: 992-1002.
5. 2+-exchanger protein levels in human heart failure. Circulation 1999; 99: 2105-12.
6. 2+ exchanger transcription a marker for different stages of myocardial dysfunctiona Quantitative polymerase chain reaction of the messenger RNA in endomyocardial biopsies of patients with heart failure. J Am Coll Cardiol 2000; 36: 233-41.
7. 2+-Exchanger protein levels and diastolic function in failing human myocardium. Circulation 1999; 99: 641-8.
8. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med 1999; 341: 577-85.
9. Bolger AP, Anker SD. Tumour necrosis factor in chronic heart failure: A peripheral view on pathogenesis, clinical manifestations and therapeutic implications. Drugs 2000; 60: 1245-57.
10. Wollert KC, Drexler H. The renin-angiotensin system and experimental heart failure. Cardiovasc Res 1999; 43: 838-49.
11. Prestle J, Dieterich S, Preuss M et al. Heterogeneous transmural gene expression of calcium-handling proteins and natriuretic peptides in the failing human heart. Cardiovasc Res 1999; 43: 323-31.
12. 2+-exchanger in adult rat ventricular cardiocytes. Cardiovasc Res 1997; 36: 216-22.
13. 2+ exchanger expression in rat cardiac myocytes. J Mol Cell Cardiol 2000; 32: 611-20.
14. Golden KL, Ren J, O'Connor J et al. In vivo regulation of Na/Ca exchanger expression by adrenergic effectors. Am J Physiol 2001; 280: H1376-H1382.
15. Barry WH, Bridge JH. Intracellular calcium homeostasis in cardiac myocytes. Circulation 1993; 87: 1806-15.
16. Agnoletti L, Curello S, Bachetti T et al. Serum from patients with severe heart failure downregulates eNOS and is proapoptotic. Role of tumor necrosis factor-a. Circulation 1999; 100: 1983-91.
17. Lown B, Wolf M. Approaches to sudden death from coronary heart disease. Circulation 1971; 44: 130-42.
18. Smedes F, Kraak JC, Poppe H. Simple and fast solvent extraction system for selective and quantitative isolation of adrenaline, noradrenaline and dopamine from plasma and urine. J Chromatogr 1982; 231: 25-39.
19. Ferrari R, Ceconi C, Rodella A, De Giuli F, Panzali A, Harris P. Temporal relations of the endocrine response to exercise. Cardioscience 1991; 2: 131-9.
20. Bisphoric NH, Simpson PC, Ordahl CP. Induction of the skeletal alpha-actin gene in alpha 1-adrenoreceptor-mediated hypertrophy of rat cardiac myocytes. J Clin Invest 1987; 80: 1194-9.
21. Takahashi N, Calderone A, Izzo NJ Jr et al. Hypertrophic stimuli induce transforming growth factor-beta 1 expression in rat ventricular myocytes (Abstr). J Clin Invest 1994; 94: 1470.
22. Bristow MR, Minobe W, Rasmussen R et al. Alphal adrenergic receptors in the nonfailing and failing human heart. J Pharmacol Exp Ther 1988; 247: 1039-45.
23. Rauchhaus M, Doehner W, Francis D et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 2000; 102: 3060-7.
24. Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. Cytokines and Cytoline Receptors in advanced heart failure. An analysis of the cytoline database from the Vesnarinone trial (VEST). Circulation 2001; 103: 2055-9.
25. Volders PG, Vos MA, Szabo B et al. Progress in the understanding of cardiac early afterdepolarizations and torsades de pointes: Time to revise current concepts. Cardiovasc Res 2000; 46: 376-92.
26. Cohn JN, Levine TB, Olivari MT et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311: 819-23.
27. 2+ exchanger expression and function in an arrhythmogenic rabbit model of heart failure. Circ Res 1999; 85: 1009-19.
28. 2+ release and Na/Ca exchange activity in hypertrophied canine ventricular myocytes. Potential link between contractile adaptation and arrhythmogenesis. Circulation 2000; 102: 2137-44.